PathAI is a paid automation & workflows tool starting at Custom quote/month. We looked at what you actually get, what real users say, and whether the price matches the value. Here's our take.
PathAI is worth it if you need automation & workflows tools. Aisight dx has fda clearance for primary diagnosis in the united states and is ce-ivd marked for primary diagnosis in the eea, uk, and switzerland. makes it a solid choice.
💰 Bottom line: Custom quote gets you ai-powered digital pathology platform providing fda-cleared digital pathology image management, biomarker analysis, and enterprise workflow management for laboratories and biopharma companies
For Custom quote, here's what that buys you:
$0/mo ÷ 8 hours saved = $0.00 per hour of value
Compare that to hiring a $automation & workflows professional at $40/hour
Even at minimum wage ($15/hr), PathAI saves you $120 over doing it manually.
We're not here to sell you PathAI. Here's what you should know before buying:
Quick comparison (not a full review):
Clinical decision support AI that assists healthcare professionals with differential diagnosis, medical knowledge search, and evidence-based clinical reasoning.
Glass AI: Better if you need their specific features
PathAI: Better if you need comprehensive features
AI-powered medical imaging platform that accelerates diagnosis and treatment of critical conditions
Viz.ai: Better if you need their specific features
PathAI: Better if you need comprehensive features
AI clinical insights platform that reviews 100% of patient charts to support hospital documentation, diagnosis capture, and revenue integrity workflows.
Regard: Better if you need Hospitals and health systems evaluating enterprise AI support for clinical documentation, diagnosis capture, and CDI workflows.
PathAI: Better if you need comprehensive features
| Use Case | Verdict | Why |
|---|---|---|
| Freelancers | ⚠️ | Affordable for solo professionals |
| Students | ⚠️ | Affordable student pricing |
| Small Teams (2-10) | ⚠️ | Check if team features are available |
| Enterprise | ⚠️ | Enterprise features and support needed |
PathAI may have a learning curve for beginners. Consider starting with tutorials and documentation before committing to paid plans.
PathAI remains relevant in 2026 with In April 2026, PathAI and MedStar Health announced a partnership to deploy the AISight Dx digital pathology platform and advanced AI applications.,In February 2026, Labcorp expanded its collaboration with PathAI to deploy the FDA-cleared AISight Dx digital pathology platform across its national network.,In February 2026, PathAI expanded the AISight Clinical Trials Platform with AIM-HI UC and IBDExplore for standardized histopathology endpoints.,PathAI continued highlighting the 2025 FDA clearance of AISight Dx for primary diagnosis, including a Predetermined Change Control Plan intended to support specified future updates without additional 510(k) submissions.,PathAI continued expanding clinical trial and biopharma positioning around AIM-MASH AI Assist, which the company says received FDA qualification for MASH clinical trials in late 2025.. The automation & workflows market continues to grow, making it a solid investment for professionals.
Check PathAI's website for current trial offerings. Many users find the paid features worth the investment for professional use.
Compare the features you actually need against each plan to find the best value for your use case.
While there are other automation & workflows tools available, PathAI's feature set and reliability often justify its pricing. Compare alternatives carefully.
Join 50,000+ builders who use AI Tools Atlas to find the right tools.
Last verified March 2026